Noopept Supplement

Noopept supplement is composed by nootropics, which enables us to adapt better to life’s challenges, by facilitating day-to-day motivation, decision-making and by improving cognitive and neurosensory processes as a whole. It improves neurotransmission quality (gabaergic, cholinergic and glutamergic), facilitates learning and increases the speed at which we process information. This is a natural way of improving memory, cognitive function and a significant aid to coping with day to day stress.

What is the Noopept suplement?

Noopept is a member of the racetam family and shares similar mechanisms of action and is widely used as an adjunct treatment for chronic cognitive and neurosensory impairment in older people. It is able to stimulate various receptors - dopaminergic (D2 and D3), cholinergic, nicotinic and serotoninergic, as well as reduce anxiety, stress and irritability, and improve mood and quality of sleep. It also increases learning ability, memory consolidation and restoration as well as logical reasoning.

What do the studies show about Noopept?

Noopept stimulates the expression of two proteins in the hippocampus - the neurotrophins NGF (nerve growth factor) and BDNF (brain derived neurotrophic factor), involved in the generation and growth of new neurons. This is a highly beneficial property since it helps neurons survive and maintains their activity. Its effect continues even after administration of Noopept ceases. It also stimulates the glutaminergic receptors AMPA and NMDA which play an essential role in memory and synaptic plasticity, thus improving cerebral performance. It is used to stimulate intelligence, cognitive function, concentration and focus. This active compound has excellent bioavailability when taken sublingually, demonstrating immediate efficacy and visible results within just five to seven days of daily use. It easily penetrates the blood-brain barrier and is thus fully active in the brain.

• This dipeptide, comprising proline and glycine (N phenylacetyl-L-prolylglycine ethyl ester), was developed in Russia and patented in 1995. It is prescribed in Russia and neighbouring countries as a nootropic and neuro-protector.
• Studies have shown promising results in relation to Alzheimer’s disease, particularly in terms of repair to damaged cells and certain receptor sites.
• One study suggests it may also offer significant benefits to sufferers of Parkinson’s disease, by blocking cytotoxic activity of amyloid oligomers.
• In addition, a study on mice showed Noopept to have anti-inflammatory effects linked to its antioxidant properties.

Noopept is recommended at doses of between one and three sublingual tablets a day and it's widely documented as safe with mild side effects observed only rarely at high doses (headaches, insomnia, nausea, fatigue). There is no dependency or interactions with other supplements or drugs that have been identified.